ZNF354C play a vital role in the dissociation of the complex from CHD1L and BCL9 promoters to abolish the transcription inhibition, suggesting its potential target for diagnosis and treatment of HCC [60]. Here, BCL9 is linked to hepatocellular carcinoma.